Total Funding
32
31
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
160069
Navigen is a drug discovery and development company creating new classes of therapies to save lives.
Dean Li: Co-FounderPast Role: Merck, Vice President & Head of Translational Medicine- Hunter Jackson: CEO & ChairmanPast Role: NPS Pharmaceuticals, Co-Founder, Chairman and CEO
About the Company
Navigen, Inc. is a Salt Lake City-based pharmaceutical discovery and development company.
Its early strategy was to source early-stage technologies from academia and advance them to IND-enabling studies using non-dilutive funding from grants, contracts, and corporate collaborations. The company has been successfully executed on that strategy,
having raised approximately $40 MM in non-dilutive funding and advancing two of its programs to pre-IND studies with the goal of filing IND applications on both within 12-14 months.
